Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00952939 · ClinicalTrials.gov registry record
Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye
A clinical trial of Intraocular Melanoma, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT00952939 is a study of Intraocular Melanoma that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 150 participants, above the 33-participant average among 3 other Intraocular Melanoma trials with a reported enrollment target (355% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00952939, a study of Intraocular Melanoma, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This clinical trial is studying tumor samples in patients undergoing surgery or radiation therapy for primary melanoma of the eye.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- OTHER Questionnaires
- PROCEDURE therapeutic conventional surgery
- GENETIC fluorescence in situ hybridization
- PROCEDURE fine-needle aspiration
Study Locations (1)
Ohio
- Cleveland Clinic Cole Eye Institute - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00952939
The ClinicalTrials.gov registry entry for NCT00952939 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 33-participant average among 3 other Intraocular Melanoma trials with a reported enrollment target (355% higher). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intraocular Melanoma appearing as the primary indexed condition, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00952939 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00952939 about?
NCT00952939 is a clinical study titled "Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye". RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This clinical trial is studying tumor samples in patients undergoing surgery or radiation therapy f...
What is the current status of trial NCT00952939?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2009-03. Estimated completion is 2014-02.
What conditions does trial NCT00952939 study?
This clinical trial studies the following conditions: Intraocular Melanoma.
What interventions are being tested in trial NCT00952939?
The interventions under investigation include: laboratory biomarker analysis (OTHER), Questionnaires (OTHER), therapeutic conventional surgery (PROCEDURE), fluorescence in situ hybridization (GENETIC), fine-needle aspiration (PROCEDURE).
Who is sponsoring clinical trial NCT00952939?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00952939 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraocular Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
COMPLETED · Phase 2
-
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
COMPLETED · Phase 2
-
Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
COMPLETED · Phase 1
-
Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
COMPLETED · Phase 2
-
Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.